Apoe and lipid mechanisms relevant to cognitive dysfunction in parkinson's disease

The Defense Health Agency awarded a $1,395,504.00 Project Grant to The Mclean Hospital Corporation Research Management Division, doing business as Mclean Hospital, for the project "APOE AND LIPID MECHANISMS RELEVANT TO COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE". The award period runs from September 1, 2023 to August 31, 2027 under the Military Medical Research and Development (CFDA 12.420) federal grant program.

Mclean Hospital, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School, will conduct research to investigate the role of the APOE gene and lipid mechanisms in cognitive dysfunction associated with Parkinson's disease. The work aims to transform health care for service members and the public through innovative and impactful research focused on medical solutions for the battlefield and other settings. Mclean Hospital has extensive experience securing and executing federal grants across neuroscience, mental health, substance abuse, and related fields, often in collaboration with elite research institutions.